Press Releases
Keyword Search
03.10.20
Curetis N.V. Shareholders Approve Planned Business Combination with OpGen
02.20.20
OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combined Key Financials and Business Update
02.12.20
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2019 and Provides Business Update
01.30.20
OpGen Provides Update on Curetis Group Company Ares Genetics’ Collaboration with BGI Group to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
01.28.20
OpGen Achieves Key Milestone in Planned Business Combination with Curetis
12.23.19
OpGen Provides Update on Curetis Group Business Receiving U.S. FDA 510(k) Clearance of its Unyvero LRT for BAL Specimens
12.02.19
OpGen Provides Curetis Group Business Update and Announces Completion of Key Milestones in Planned Business Combination
11.19.19
OpGen Products in Development to Address “Urgent Threat” Pathogens Highlighted in New CDC Report on Antibiotic Resistance Threats
11.06.19
OpGen Reports Third Quarter 2019 Financial Results and Provides Business Update
11.04.19
OpGen Provides Update on Curetis Group Company Ares Genetics Business